Pay in 4 interest-free payments of $6.35 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Schnzer W, Thevis M
Choose BPC-157 if: Single specific injury needs treatment
come in for a personalized consultation to see if B12 therapy is right for you
Trial-Reported Endpoints by Phase Trial Lancet 2021 Phase 2 Duration 26 weeks Population Overweight/obese, no T2D (n=706) Mean Weight Loss 10.8% at 4.5 mg vs 3.0% placebo Trial Lancet 2023 Phase 2 Duration 32 weeks Population T2D + obesity (n=92) Mean Weight Loss 8.1% cagrilintide alone
It works specifically within the gut to calm immune overactivation, reduce inflammatory cytokine signaling, and restore the mucosal barrier that separates your gut contents from your bloodstream
Perhaps most telling, researchers tested for anti-AOD 9604 antibodies at multiple timepoints throughout the trials
US$ 29.53
US$ 21.57
US$ 23.19
US$ 29.30
US$ 27.37
US$ 22.08
US$ 26.51
US$ 27.68
US$ 29.87
US$ 28.41
US$ 25.29
